Sallykortam (Talk | contribs) |
Sallykortam (Talk | contribs) |
||
Line 114: | Line 114: | ||
<ol class="protocols"> | <ol class="protocols"> | ||
<li><a target="_blank" href= "https://static.igem.org/mediawiki/2017/9/93/T--TECHNION-ISRAEL--Transfection_to_HPC-7_with_lipofectamine_2000.pdf">Transfection with Lipofectamine 2000</a></li> | <li><a target="_blank" href= "https://static.igem.org/mediawiki/2017/9/93/T--TECHNION-ISRAEL--Transfection_to_HPC-7_with_lipofectamine_2000.pdf">Transfection with Lipofectamine 2000</a></li> | ||
− | <li><a target="_blank" href=" https://static.igem.org/mediawiki/2017/ | + | <li><a target="_blank" href=" https://static.igem.org/mediawiki/2017/8/89/T--TECHNION-ISRAEL--Splitting_for_HPC-7_cells.PDF">Splitting</a></li> |
<li><a target="_blank" href="https://static.igem.org/mediawiki/2017/7/74/T--TECHNION-ISRAEL--Multiporator_optimization.pdf">Multiporator Optimization</a></li> | <li><a target="_blank" href="https://static.igem.org/mediawiki/2017/7/74/T--TECHNION-ISRAEL--Multiporator_optimization.pdf">Multiporator Optimization</a></li> | ||
</ol> | </ol> |
Revision as of 10:37, 30 October 2017